Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
19.07
-0.39 (-2.00%)
Mar 31, 2025, 10:57 AM EDT - Market open

Cellebrite DI Statistics

Total Valuation

Cellebrite DI has a market cap or net worth of $4.57 billion. The enterprise value is $4.19 billion.

Market Cap 4.57B
Enterprise Value 4.19B

Important Dates

The next estimated earnings date is Thursday, May 22, 2025, before market open.

Earnings Date May 22, 2025
Ex-Dividend Date n/a

Share Statistics

Cellebrite DI has 239.47 million shares outstanding. The number of shares has increased by 10.16% in one year.

Current Share Class 239.47M
Shares Outstanding 239.47M
Shares Change (YoY) +10.16%
Shares Change (QoQ) +18.52%
Owned by Insiders (%) 2.71%
Owned by Institutions (%) 37.14%
Float 107.37M

Valuation Ratios

PE Ratio n/a
Forward PE 47.27
PS Ratio 10.16
Forward PS 9.44
PB Ratio 13.58
P/TBV Ratio 15.74
P/FCF Ratio 37.70
P/OCF Ratio 35.26
PEG Ratio 3.12
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 62.02, with an EV/FCF ratio of 33.88.

EV / Earnings n/a
EV / Sales 10.44
EV / EBITDA 62.02
EV / EBIT 73.58
EV / FCF 33.88

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.03.

Current Ratio 1.92
Quick Ratio 1.79
Debt / Equity 0.03
Debt / EBITDA 0.15
Debt / FCF 0.09
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -152.88% and return on invested capital (ROIC) is 17.99%.

Return on Equity (ROE) -152.88%
Return on Assets (ROA) 5.81%
Return on Invested Capital (ROIC) 17.99%
Return on Capital Employed (ROCE) 14.40%
Revenue Per Employee $343,790
Profits Per Employee -$242,508
Employee Count 1,167
Asset Turnover 0.66
Inventory Turnover 6.63

Taxes

In the past 12 months, Cellebrite DI has paid $7.02 million in taxes.

Income Tax 7.02M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +72.83% in the last 52 weeks. The beta is 1.52, so Cellebrite DI's price volatility has been higher than the market average.

Beta (5Y) 1.52
52-Week Price Change +72.83%
50-Day Moving Average 20.82
200-Day Moving Average 17.94
Relative Strength Index (RSI) 47.76
Average Volume (20 Days) 1,235,931

Short Selling Information

The latest short interest is 1.28 million, so 0.53% of the outstanding shares have been sold short.

Short Interest 1.28M
Short Previous Month 1.07M
Short % of Shares Out 0.53%
Short % of Float 1.19%
Short Ratio (days to cover) 0.54

Income Statement

In the last 12 months, Cellebrite DI had revenue of $401.20 million and -$283.01 million in losses. Loss per share was -$1.35.

Revenue 401.20M
Gross Profit 338.61M
Operating Income 56.91M
Pretax Income -106.25M
Net Income -283.01M
EBITDA 67.51M
EBIT 56.91M
Loss Per Share -$1.35
Full Income Statement

Balance Sheet

The company has $447.22 million in cash and $10.97 million in debt, giving a net cash position of $472.86 million or $1.97 per share.

Cash & Cash Equivalents 447.22M
Total Debt 10.97M
Net Cash 472.86M
Net Cash Per Share $1.97
Equity (Book Value) 336.02M
Book Value Per Share 1.43
Working Capital 272.09M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $132.17 million and capital expenditures -$8.57 million, giving a free cash flow of $123.61 million.

Operating Cash Flow 132.17M
Capital Expenditures -8.57M
Free Cash Flow 123.61M
FCF Per Share $0.52
Full Cash Flow Statement

Margins

Gross margin is 84.40%, with operating and profit margins of 14.18% and -70.54%.

Gross Margin 84.40%
Operating Margin 14.18%
Pretax Margin -68.79%
Profit Margin -70.54%
EBITDA Margin 16.83%
EBIT Margin 14.18%
FCF Margin 30.81%

Dividends & Yields

Cellebrite DI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.16%
Shareholder Yield -10.16%
Earnings Yield -6.07%
FCF Yield 2.65%
Dividend Details

Analyst Forecast

The average price target for Cellebrite DI is $23.43, which is 22.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target $23.43
Price Target Difference 22.86%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 16.47%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Cellebrite DI has an Altman Z-Score of 5.93 and a Piotroski F-Score of 5.

Altman Z-Score 5.93
Piotroski F-Score 5